Trametinib in neurofibromatosis type 1 related symptomatic plexiform neurofibromas
This research study is investigating a medication called Mekinist. Mekinist comes as a tablet, and the study is for adults who have Neurofibromatosis Type 1 (NF1) and are experiencing bothersome or painful nerve tumours, called plexiform neurofibromas. The main goal is to find out if Mekinist can make these tumours smaller. Researchers will also look at how the treatment might affect pain levels, general well-being, and overall health. This is an important step to see if Mekinist could be a helpful treatment option for people living with NF1.
نظرة سريعة
ما هو موضوع هذه الدراسة؟
This study is looking at a new way to treat a condition called Neurofibromatosis Type 1, often shortened to NF1. People with NF1 can develop various growths, including something called plexiform neurofibromas. These are non-cancerous tumours that grow along nerves and can sometimes cause pain or other problems.
The study is using a tablet medication called Mekinist (with the active ingredient trametinib). The main aim is to see if taking Mekinist can shrink these nerve tumours. Doctors will use special MRI scans to measure the size of the tumours before and during the study to see if they get smaller.
Apart from tumour size, the researchers also want to understand how this treatment might affect a person's daily life. They'll be looking at things like how much pain a person experiences, their overall quality of life, and if the treatment causes any side effects. This type of study (a Phase II trial) helps us learn more about how well a new treatment works and if it's safe for people.
النقاط الرئيسية
- This study is testing a new tablet medicine (Mekinist) for adults with NF1.
- It aims to see if Mekinist can shrink painful or problematic nerve tumours.
- Researchers will also track improvements in pain and overall quality of life.
- Participants will have regular MRI scans and health checks.
- Joining is voluntary, and you can stop at any time.
من قد يكون مؤهلاً؟
للانضمام إلى هذه الدراسة، يجب أن تكون بالغًا، بعمر 18 عامًا أو أكثر. لا يوجد حد أقصى للعمر، لذا يمكن للبالغين الأكبر سنًا أيضًا المشاركة.
Both men and women are welcome to participate in this research. The study is specifically for individuals who have been diagnosed with Neurofibromatosis Type 1 (NF1).
If you have NF1 and are experiencing symptoms from plexiform neurofibromas, such as pain or other difficulties, this study might be for you. The research team will check other specific medical details to make sure the study is a safe and good fit for your individual health.
هل يمكن أن تناسبك هذه الدراسة؟
أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.
- هل عمرك 18 سنة أو أكثر؟
- Have you been diagnosed with Neurofibromatosis Type 1 (NF1)?
- Are you experiencing symptoms from plexiform neurofibromas (nerve tumours)?
- Are you able to take tablets as prescribed?
ماذا يتضمن المشاركة؟
If you decide to take part in this study, you would be asked to take the Mekinist tablets as prescribed. You would have regular appointments for follow-up. These appointments would likely include MRI scans to measure your tumours, as well as discussions about any pain you might be experiencing and your general well-being. You would also fill out questionnaires about how you are feeling and have photos taken of certain areas. Doctors would carefully check for any side effects you might have. The total duration of your participation would depend on how the treatment works for you and the study's design.
المخاطر والفوائد المحتملة
المواقع (1)
- —غير مؤكدهولندا
أسئلة شائعة
What is Neurofibromatosis Type 1 (NF1)?
NF1 is a genetic condition that causes tumours to grow on nerves, usually non-cancerous, which can affect many parts of the body.
What are plexiform neurofibromas?
These are specific types of nerve tumours that can occur in people with NF1 and can sometimes cause pain or other problems.
What is Mekinist?
Mekinist is a tablet medication being studied to see if it can help shrink plexiform neurofibromas in people with NF1.
Will I get paid to be in this study?
Clinical trials usually don't pay you to participate, but often cover travel costs or other study-related expenses. You should ask the research team about this.
كم ستستغرق مدة الدراسة؟
The exact duration will vary for each person, depending on their response to treatment and the study plan. The study team can give you more details.
كيفية معرفة المزيد
تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.
نقاش
مناقشة المجتمع
مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.